For the quarter ending 2026-03-31, CLYM has $152,372K in assets. $4,287K in debts. $8,356K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 8,356 | 35,685 | 25,803 | 22,682 |
| Short-term marketable securities | 101,208 | 65,395 | 61,098 | 62,021 |
| Prepaid expenses and other current assets | 3,840 | 4,769 | 4,063 | 2,681 |
| Total current assets | 113,404 | 105,849 | 90,964 | 87,384 |
| Long-term marketable securities | 36,741 | 59,572 | 88,930 | 102,702 |
| Operating lease right-of-use assets | 447 | 505 | 562 | 618 |
| Property and equipment, net | 250 | 288 | 318 | 314 |
| Other long-term assets | 1,530 | 1,530 | 1,530 | 1,368 |
| Total assets | 152,372 | 167,744 | 182,304 | 192,386 |
| Accounts payable | 860 | 2,269 | 477 | 946 |
| Accrued external research and development expenses | 1,318 | - | - | - |
| Accrued payroll and related expenses | 984 | - | - | - |
| Accrued professional fees | 533 | - | - | - |
| Other accrued expenses and current liabilities | 113 | - | - | - |
| Accrued expenses and other current liabilities | 2,948 | 4,459 | 4,244 | 5,037 |
| Operating lease liabilities | 263 | 256 | 228 | 222 |
| Total current liabilities | 4,071 | 6,984 | 4,949 | 6,205 |
| Operating lease liabilities, net of current portion | 216 | 285 | 352 | 417 |
| Total liabilities | 4,287 | 7,269 | 5,301 | 6,622 |
| Common stock, 0.0001 par value 250,000,000 shares authorized 47,768,543 and 47,766,338 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 5 | 5 | 7 | 7 |
| Additional paid-in capital | 451,372 | 449,762 | 448,738 | 444,762 |
| Accumulated other comprehensive loss | 157 | 435 | 469 | 318 |
| Accumulated deficit | -303,449 | -289,727 | -272,211 | -259,323 |
| Total stockholders' equity | 148,085 | 160,475 | 177,003 | 185,764 |
| Total liabilities and stockholders' equity | 152,372 | 167,744 | 182,304 | 192,386 |
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)